Care.com (NASDAQ:CRCM) last issued its quarterly earnings data on Thursday, July 31st. The company reported ($0.27) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.33) by $0.06. The company had revenue of $25.80 million for the quarter, compared to the consensus estimate of $26.00 million. Care.com’s revenue was up 35.1% compared to the same quarter last year. On average, analysts predict that Care.com will post $-1.38 earnings per share for the current fiscal year. Care.com, Inc. (NYSE:CRCM) in last trading activity moved down -0.62% to close at $8.05. Company weekly performance is -1.59% while its quarterly performance stands at -26.15%. Care.com, Inc. (NYSE:CRCM) is -72.48% away from its 52 week high.The Ibovespa dropped the most among global stock indexes as polls showing opposition candidate Aecio Neves tied with President Dilma Rousseff before this month’s runoff disappointed investors betting on the incumbent’s defeat. Itau Unibanco Holding SA contributed the most to the gauge’s decline. On last trading day Itau Unibanco Holding SA (ADR) (NYSE:ITUB) moved down -5.65% to close at $14.53. Its volatility for the week is 3.75% while volatility for the month is 3.45%. ITUB's sales growth for past 5 years was 14.60% and its EPS growth for past 5 years was 19.40%. Itau Unibanco Holding SA (ADR) (NYSE:ITUB) monthly performance is -13.10%.A number of research firms have recently commented on Alamos Gold Inc. (NYSE:AGI). Analysts at Canaccord Genuity cut their price target on shares of Alamos Gold from C$13.50 to C$11.50 in a research note on Monday. They now have a “buy” rating on the stock. On last trading day Alamos Gold Inc. (NYSE:AGI) moved down -3.48% to close at $8.31. Its volatility for the week is 6.92% while volatility for the month is 4.18%. AGI's EPS growth for past 5 years was -25.06%. Alamos Gold Inc. (NYSE:AGI) monthly performance is -6.31%.Tetraphase Pharmaceuticals (NASDAQ:TTPH) last announced its earnings results on Tuesday, August 12th. The company reported ($0.71) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.54) by $0.17. The company had revenue of $1.30 million for the quarter, compared to the consensus estimate of $2.79 million. On average, analysts predict that Tetraphase Pharmaceuticals will post $-2.34 EPS for the current fiscal year. Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) has 0.60% insider ownership while its institutional ownership stands at 73.80%. In last trading activity company's stock closed at $24.00.Advanced Micro Devices, Inc. (NYSE:AMD) fell after the chipmaker said CEO and president Rory Read was stepping down. Advanced Micro Devices, Inc. (NYSE:AMD) in last trading activity moved down -7.80% to close at $2.72. Company weekly performance is -20.00% while its quarterly performance stands at -41.38%. Advanced Micro Devices, Inc. (NYSE:AMD) is -43.33% away from its 52 week high.Advanced Micro Devices, Inc. (NYSE:AMD) in last trading activity moved down -7.80% to close at $2.72. Company weekly performance is -20.00% while its quarterly performance stands at -41.38%. Advanced Micro Devices, Inc. (NYSE:AMD) is -43.33% away from its 52 week high.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
